1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Programme

10.00-10.15

Welcome and Introduction - Prof Anthony Chalmers

   

10.15-11.45

Radiotherapy technology and clinical trials

Chair: Dr Stefano Schipani

  • Intraoperative radiotherapy in the clinic - Prof Alastair Munro (Dundee)
  • Stereotactic ablative radiotherapy for lung cancer - Dr Claire Paterson (Glasgow)
  • Improving radiotherapy for breast cancer through well-designed clinical trials - Prof John Yarnold (Marsden)

11.45-12.00

Coffee

   

12.00-13.00

Combining radiotherapy with novel drug therapies

Chair: Professor David Gillespie

  • The rationale for combining radiotherapy with inhibitors of DNA repair - Prof Anthony Chalmers (Glasgow)
  • Targeting radiation induced signal transduction pathways - Dr Geoff Higgins (Oxford)

13.00-14.00

Lunch

   

14.00-15.30

Radionuclide therapy of neuroblastoma

Chair: Prof Rob Mairs

  • Experimental MIBG therapy: lab to clinic - Prof Rob Mairs (Glasgow)
  • MIBG and topotecan combination therapy - Dr Mark Gaze(UCL)
  • Treatment of neuroblastoma in Glasgow: present and future - Dr Dermot Murphy (Glasgow)

15.30-15.45

Tea

   

15.45-16.45

AGM and discussion

  • An overview of CTRad - Professor Neil Burnet, (CTRad Vice Chair)
  • Enhancing radiotherapy research in Scotland - All/Anthony Chalmers

16.45-17.00

Closing Remarks